Page 39 - Mark Mcclellan News Today

CDC reports record number of daily Covid-19 vaccinations as states struggle with supply CNN 1/23/2021 By Theresa Waldrop, Madeline Holcombe and Jason Hanna, CNN © Harrison Hill/USA TODAY/Sipa USA Jan 7, 2021; Mission Hill, CA, USA; Ararat House registered nurse Arpa Davoudian prepares to administer a COVID-19 vaccine to a resident at the Ararat House Nursing Facility on Jan. 7, 2021.. Mandatory Credit: Harrison Hill-USA TODAY/Sipa USA The US Centers for Disease Control and ...

The US can vaccinate up to 85% of adults and begin a return to normal by fall, Fauci says Despite challenges with distributing and administering Covid-19 vaccines, the US “can and should” vaccinate 70-85% of adults by the end of summer, infectious disease expert Dr. Anthony Fauci says. That could bring a semblance of normalcy by the fall, according to Fauci, the director of the National Institute of Allergy and Infectious Diseases. “When you put … the pedal to the floor, you can get it ...

POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by CVS Health On Tap — Wanted: An FDA commissioner as ambitious Biden vaccine goals are touted. — President Joe Biden looks t...

Share:  Johnson & Johnson (NYSE: JNJ) is on track to analyze data from its late-stage single-dose COVID-19 vaccine trial. Dr. Anthony Fauci said in his remarks at the White House that JNJ has enough data to begin analysis in a week or two. What Happened: In December, JNJ said it had enrolled roughly 45,000 participants in the “Ensemble” trial, which is being conducted by its Janssen unit. It expects interim data from the trial by the end of January. JNJ anticipates applying for emergen...

An average of 1.06 million doses were administered per day over the last week, according to a Bloomberg News tracker, as states expand eligibility to American seniors and get better at reaching people who want the vaccine. Congressional Republicans are poking Mr. Biden, saying former President Donald Trump put the Democrat in a position to meet his pledge from the start and that he should find ways to double his goal — particularly since a growing share of available shots will be devoted to s...

The Biden team’s handwringing has left an agency central to the pandemic fight without a permanent leader.

Dive Brief: Janet Woodcock, head of the Food and Drug Administrations drug review division, will serve as acting commissioner of the agency while President Joseph Biden decides on a permanent chief. She is one of several current and former high-ranking FDA officials believed to be under consideration for the permanent job. Detailed last year to the former Trump administrations coronavirus response team, Operation Warp Speed, Woodcock will recuse herself from FDA decisions involving certain COVI...

For nearly the entire pandemic, political polarization and a rejection of science have stymied the United States’ ability to control the coronavirus.

Read more about One year, 400,000 coronavirus deaths: How US guaranteed its own failure on Business Standard. After the White House declined to pursue a unified national strategy, governors faced off against lobbyists, health experts, and a restless public consumed by misinformation

Why was Texas unable to stop a second COVID surge months in the making? FacebookTwitterEmail 1of5 Memorial Hermann Hospital RN Jacqueline Uwanda prepares to enter a COVID patients room inside a 38-bed ICU treating mostly COVID patients, Tuesday, Jan. 5, 2021, in Houstons Texas Medical Center.Mark Mulligan, Houston Chronicle / Staff photographerShow MoreShow Less 2of5A "Bar Open" sign lights the way to a bar along Main Street on Thursday, Jan. 14, 2021, in downtown Houston.Mark Mulligan/Staff ph...